Successful treatment of pediatric Tolosa-Hunt syndrome with adalimumab.

Published in: European journal of rheumatology (2019)

Adalimumab, a subcutaneous TNFi, appears to be an effective treatment for corticosteroid-dependent THS.

Keyphrases